AVXL rated Hold: strong $131.7M cash runway, but blarcamesine’s upside hinges on clearer efficacy and FDA approval.
Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
RightLivin on MSN
How FM radio became the soundtrack of an entire generation
FM radio didn't just play music — it rewired how a generation listened.
Too many cat owners think these behaviors are normal — but vets say they could even be life-threatening if ignored.
Walnut Media has acquired Omaha's AM 590, reviving the historic WOW call letters and becoming the new Omaha-area home for ...
Aurenar’s V-Link system uses transauricular vagus nerve stimulation to modulate brain inflammation in patients that have ...
Information Station Specialists will begin accepting orders for its Magnum k1 Antenna for AM radio stations this weekend.
Teams competing in the Tour Auvergne-Rhone-Alpes last month were able to practice their TTT skills ANNE-CHRISTINE POUJOULAT/Getty Images A team time trial in full motion is a glorious sight. The ...
Pairing sensing leadership with a complete ASIL-D safety PMIC architecture, the single-chip A81415 redefines brake-by-wire ...
Almost every conversation about AM radio starts the same way: “When’s the last time you even used it?” That’s a fair question, but there’s an entire cohort of people who believe it’s the wrong one.
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results